Logo image of NUW

NUVEEN AMT-FREE MUNI VAL (NUW) Stock Price, Quote, News and Overview

NYSE:NUW - New York Stock Exchange, Inc. - US6706951059 - Currency: USD

13.58  +0.01 (+0.07%)

Fundamental Rating

2

NUW gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NUW may be in some trouble as it scores bad on both profitability and health. NUW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NUW was profitable.
Of the past 5 years NUW 4 years were profitable.
NUW had a negative operating cash flow in each of the past 5 years.
NUW Yearly Net Income VS EBIT VS OCF VS FCFNUW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Industry RankSector Rank
ROA 3.35%
ROE 3.39%
ROIC 2.76%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUW Yearly ROA, ROE, ROICNUW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

In the last couple of years the Profit Margin of NUW has remained more or less at the same level.
NUW's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of NUW has remained more or less at the same level.
Industry RankSector Rank
OM 84.12%
PM (TTM) 80.85%
GM 84.9%
OM growth 3Y1.98%
OM growth 5Y0.62%
PM growth 3Y13.77%
PM growth 5Y-0.04%
GM growth 3Y1.07%
GM growth 5Y0.1%
NUW Yearly Profit, Operating, Gross MarginsNUW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for NUW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NUW Yearly Shares OutstandingNUW Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M
NUW Yearly Total Debt VS Total AssetsNUW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

NUW has an Altman-Z score of 49.88. This indicates that NUW is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that NUW is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 49.88
ROIC/WACCN/A
WACCN/A
NUW Yearly LT Debt VS Equity VS FCFNUW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.3 Liquidity

NUW has a Current Ratio of 1.93. This is a normal value and indicates that NUW is financially healthy and should not expect problems in meeting its short term obligations.
NUW has a Quick Ratio of 1.93. This is a normal value and indicates that NUW is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
NUW Yearly Current Assets VS Current LiabilitesNUW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 119.49% over the past year.
Measured over the past years, NUW shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.91% on average per year.
Looking at the last year, NUW shows a small growth in Revenue. The Revenue has grown by 5.77% in the last year.
Measured over the past years, NUW shows a decrease in Revenue. The Revenue has been decreasing by -0.04% on average per year.
EPS 1Y (TTM)119.49%
EPS 3Y18.43%
EPS 5Y-2.91%
EPS Q2Q%22.08%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y3.96%
Revenue growth 5Y-0.04%
Sales Q2Q%5.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUW Yearly Revenue VS EstimatesNUW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.29, which means the current valuation is very expensive for NUW.
When comparing the Price/Earnings ratio of NUW to the average of the S&P500 Index (27.91), we can say NUW is valued inline with the index average.
Industry RankSector Rank
PE 28.29
Fwd PE N/A
NUW Price Earnings VS Forward Price EarningsNUW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUW Per share dataNUW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NUW has a Yearly Dividend Yield of 3.88%. Purely for dividend investing, there may be better candidates out there.
NUW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.88%

5.2 History

NUW has paid a dividend for at least 10 years, which is a reliable track record.
NUW has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
NUW Yearly Dividends per shareNUW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NUW Yearly Income VS Free CF VS DividendNUW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

More info and screens

NUVEEN AMT-FREE MUNI VAL

NYSE:NUW (7/29/2025, 7:00:00 PM)

13.58

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners37.15%
Inst Owner Change0.9%
Ins OwnersN/A
Ins Owner Change0%
Market Cap243.76M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield 3.88%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-Date07-15 2025-07-15 (0.0485)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.29
Fwd PE N/A
P/S 22.83
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)0.48
EY3.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.59
BVpS14.2
TBVpS14.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.35%
ROE 3.39%
ROCE 3.5%
ROIC 2.76%
ROICexc 2.78%
ROICexgc 2.78%
OM 84.12%
PM (TTM) 80.85%
GM 84.9%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.98%
OM growth 5Y0.62%
PM growth 3Y13.77%
PM growth 5Y-0.04%
GM growth 3Y1.07%
GM growth 5Y0.1%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 49.88
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.49%
EPS 3Y18.43%
EPS 5Y-2.91%
EPS Q2Q%22.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.77%
Revenue growth 3Y3.96%
Revenue growth 5Y-0.04%
Sales Q2Q%5.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.67%
EBIT growth 3Y6.02%
EBIT growth 5Y0.58%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A